FG receives long-acting injectable Lenacapavir for HIV prevention

The Federal Government has received the long-acting injectable Lenacapavir (LEN) for use as Pre-Exposure Prophylaxis (PrEP) in the prevention of HIV/AIDS, marking a significant step in expanding the country’s HIV prevention options.